These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 11142033)
1. Non-invasive in vivo imaging of transplant function. Brooks DJ; Piccini P Prog Brain Res; 2000; 127():321-32. PubMed ID: 11142033 [No Abstract] [Full Text] [Related]
2. Assessment of fetal tissue transplantation in Parkinson's disease: does PET play a role? Martin WR; Perlmutter JS Neurology; 1994 Oct; 44(10):1777-80. PubMed ID: 7936219 [No Abstract] [Full Text] [Related]
3. Neuropathology of fetal nigra transplants for Parkinson's disease. Kordower JH; Sortwell CE Prog Brain Res; 2000; 127():333-44. PubMed ID: 11142034 [No Abstract] [Full Text] [Related]
4. Images in neuroscience. Neuroimaging, XII. SPECT imaging of dopamine nerve terminals. Seibyl JP; Marek K; Innis RB Am J Psychiatry; 1996 Sep; 153(9):1131. PubMed ID: 8780413 [No Abstract] [Full Text] [Related]
7. Can SPET imaging of dopamine uptake sites replace PET imaging in Parkinson's disease? For. Tatsch K Eur J Nucl Med Mol Imaging; 2002 May; 29(5):711-4. PubMed ID: 11976813 [No Abstract] [Full Text] [Related]
8. The role of positron emission tomography in the assessment of human neurotransplantation. Sawle GV; Myers R Trends Neurosci; 1993 May; 16(5):172-6. PubMed ID: 7685938 [TBL] [Abstract][Full Text] [Related]
9. Neural transplantation for the treatment of Huntington's disease. Freeman TB; Hauser RA; Sanberg PR; Saporta S Prog Brain Res; 2000; 127():405-11. PubMed ID: 11142038 [No Abstract] [Full Text] [Related]
10. Aspects of PET imaging relevant to the assessment of striatal transplantation in Huntington's disease. Besret L; Kendall AL; Dunnett SB J Anat; 2000 May; 196 ( Pt 4)(Pt 4):597-607. PubMed ID: 10923990 [TBL] [Abstract][Full Text] [Related]
11. Transplantation in the rat model of Parkinson's disease: ectopic versus homotopic graft placement. Winkler C; Kirik D; Björklund A; Dunnett SB Prog Brain Res; 2000; 127():233-65. PubMed ID: 11142030 [No Abstract] [Full Text] [Related]
12. Striatal dopamine D2 receptor alterations and response to L-DOPA in Parkinson's disease. A [123I]IBZM SPET study. Pizzolato G; Cagnin A; Rossato A; Chierichetti F; Fabbri M; Dam M; Ferlin G; Battistin L Adv Neurol; 1996; 69():467-73. PubMed ID: 8615167 [No Abstract] [Full Text] [Related]
14. Regulation of dopamine cell type and transmitter function in fetal and stem cell transplantation for Parkinson's disease. Björklund LM; Isacson O Prog Brain Res; 2002; 138():411-20. PubMed ID: 12432781 [No Abstract] [Full Text] [Related]
15. Regional kinetics of [11C]methylspiperone in the brain studied by positron emission tomography in patients with Parkinson's disease. Hägglund J; Aquilonius SM; Bergström K; Eckernäs SA; Hartvig P; Lundqvist H; Långström B; Malmborg P; Någren K Adv Neurol; 1987; 45():99-101. PubMed ID: 2950732 [No Abstract] [Full Text] [Related]
16. Clinical observations after neural transplantation in Parkinson's disease. Lindvall O; Hagell P Prog Brain Res; 2000; 127():299-320. PubMed ID: 11142032 [No Abstract] [Full Text] [Related]
18. [Diagnostic use of SPECT with visualization of dopamine transporters in Parkinson disease. The Danish Society of Neurology]. Løkkegaard A; Friberg L Ugeskr Laeger; 2003 Mar; 165(12):1247. PubMed ID: 12701297 [No Abstract] [Full Text] [Related]
19. Nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET. Tissingh G; Bergmans P; Winogrodzka A; Stoof JC; Wolters EC; Booij J; Van Royen EA J Nucl Med; 1997 Aug; 38(8):1271-2. PubMed ID: 9255164 [No Abstract] [Full Text] [Related]
20. Physiologic modeling of PET data: quantitative conflict and challenge. Ichise M; Ballinger JR J Nucl Med; 1997 Aug; 38(8):1266-7. PubMed ID: 9255162 [No Abstract] [Full Text] [Related] [Next] [New Search]